Multimodal biomicroscopic system enhances the accuracy of cancer treatment

January 9, 2018, Daegu Gyeongbuk Institute of Science and Technology
Conceptual diagram showing characteristics of Multimodal Biomicroscopic System. Credit: Daegu Gyeongbuk Institute of Science and Technology (DGIST)

A research team of Information and Communication Engineering at DGIST has developed the world's first multimodal biomicroscopic system to analyze the characteristics of tumors and to utilize them in tumor treatment technology research. The new imaging system accurately analyzes the characteristics of tumors using the mechanical, chemical, and structural properties of colorectal cancer. It is the result of a collaboration with the research team of Eunjoo Kim from the Department of Nano & Energy Research.

Histopathologic examination of tumors removed during surgery is important. In particular, if a small part of the tumor is left in the patient, it becomes the cause of cancer recurrence or metastasis. Therefore, it is necessary to accurately analyze the removed tumor to find out whether cancer remains in the surgical site.

For analysis, it is necessary to send a resected tumor to a pathologist to examine the specimen with a microscope to determine whether the resected cancer tissue is appropriately acquired and whether additional resection of the tissue during surgery is necessary. However, this process is time consuming, and the results may vary depending on internal and external factors. To overcome these disadvantages, optical microscopy or ultrasonic wave technology are used. However, it is difficult to perform close inspection, as these methods have low resolution and cannot analyze the tissue internally.

Professor Hwang's research team has developed a converged biomicroscope based on high-frequency ultrasound and optical spectroscopy to overcome the disadvantages of the imaging systems previously developed for tumor analysis. The multimodal biomicroscopic system is capable of performing pathologic analysis simultaneously to detect the surface of resected tissues and tumors deep within the tissues during the cancer operation. It converges optical multispectral imaging, high-frequency ultrasound B-mode, and high-frequency ultrasound radiation imaging techniques.

Tissue and tumor areas can be analyzed more precisely than via a general fluorescence microscope as the optical spectroscopic imaging technique quantitatively analyzes the spectroscopic indicators emitted from the tissue surface. It is possible to detect deep tissue as well as tumor areas accurately with high frequency ultrasonic b-mode and high frequency ultrasonic radiation force imaging technique, as they image the impedance and elasticity inside the tissue at higher resolution than the existing ultrasonic imaging techniques.

Through the experiment, the research team has proved that multimodal biomicroscopic system enables mechanical, chemical, and structural analysis of the tumor from colon cancer patients at the high resolution from the surface to the deep of the tumor.

Professor Hwang said, "We have developed a multimodal biomicroscopic system based on high-frequency ultrasound and optical spectroscopy for the first time. It complements the disadvantages of the existing image analysis systems. We will conduct further studies to develop this system to the endoscope system which can be used for clinical diagnosis of cancer before the actual surgery."

The results of this study show that the multimodal biomicroscopic system has the potential to qualitatively investigate the characteristics of incised tumors in vitro. The multimodal biomicroscopic system is expected to improve the efficiency and success rate of surgery by increasing the accuracy of removal surgery as well as shortening the operation time.

Explore further: Multifunctional fluorescent nanoparticles for cancer surgery show promise

More information: Jihun Kim et al, A Multimodal Biomicroscopic System based on High-frequency Acoustic Radiation Force Impulse and Multispectral Imaging Techniques for Tumor Characterization Ex vivo, Scientific Reports (2017). DOI: 10.1038/s41598-017-17367-1

Related Stories

Multifunctional fluorescent nanoparticles for cancer surgery show promise

November 14, 2017
Even with pre-operative imaging techniques, surgeons still rely on visual inspection to locate malignant tissues during surgery. New research released today at the 2017 American Association of Pharmaceutical Scientists (AAPS) ...

Precise 3-D imaging of skin cancer tumours

November 15, 2017
Scientists and clinicians from Singapore and Germany have successfully used multispectral optoacoustic tomography (MSOT) to achieve accurate, real-time 3-D imaging of non-melanoma skin cancer tumours. This imaging technique ...

Recommended for you

New breath and urine tests detect early breast cancer more accurately

April 25, 2018
A new method for early and accurate breast cancer screening has been developed by researchers at Ben-Gurion University of the Negev and Soroka University Medical Center, using commercially available technology.

Do prostate cancer cells have an Achilles' heel?

April 25, 2018
Researchers at the University of Illinois at Chicago describe new ways to selectively kill prostate cancer cells by exploiting the cells' revved-up metabolism. They report their findings in the online journal, eLife.

Research shows possible new target for immunotherapy for solid tumors

April 24, 2018
Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

Changes in breast tissue increase cancer risk for older women

April 24, 2018
Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April ...

Targeting molecules called miR-200s and ADAR2 could prevent tumor metastasis in patients with colorectal cancer

April 24, 2018
Colorectal cancer is the third most common cancer worldwide and the third-leading cause of cancer-related deaths. The main cause of death in patients with colorectal cancer is liver metastasis, with nearly 70% of patients ...

Experimental arthritis drug prevents stem cell transplant complication

April 24, 2018
An investigational drug in clinical trials for rheumatoid arthritis prevents a common, life-threatening side effect of stem cell transplants, new research from Washington University School of Medicine in St. Louis shows. ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.